Live tape
Top 8, mentions 7d17,623MSFT3,323 mentions▲ +0.08GOOGL2,699 mentions▲ +0.05AAPL2,316 mentions▲ +0.07META2,238 mentions▲ +0.04SPCX1,995 mentions▲ +0.06SNDK1,864 mentions▲ +0.06NVDA1,758 mentions▲ +0.07QQQ1,430 mentions▲ +0.04

Equity · Healthcare

MTD

Mettler-Toledo International Inc. · NYSE

$1,310.45 −1.91% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView

The chart above plots the price of MTD over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 55 sessions over that window: $1,268.00 on 1 May 2026 through $1,310.45 on 17 July 2026. Finazon · prior-day close.

Market cap $26.5B
P/E (TTM) 35.9
52-week range $1,024.00 – $1,524.99
Avg volume 60.1K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

MTD insider trades

SEC Form 4 · last 90 days · newest reported trade 12 May 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 6
Compensation mechanics (6 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
12 May 2026 Graham-Bryce Susan Chief Human Resources Officer Award 71
12 May 2026 Kaltenbach Patrick President and CEO Award 810
12 May 2026 Keller Gerry Head of Process Analytics Award 100
12 May 2026 Vadala Shawn Chief Financial Officer Award 291
12 May 2026 Wittorf Oliver Head of PI, Retail, and GSC Award 87
12 May 2026 Wong Ann Ping Richard Head of Asia & Pacific Award 103

MTD reported financials

SEC EDGAR XBRL

MTD reported revenue of $4.0B for the fiscal year ended 31 Dec 2025. Net income over the same period was $869.2M.

Figure Reported Period
Revenue $4.0B 31 Dec 2025 fiscal year
Net income $869.2M 31 Dec 2025 fiscal year
Diluted EPS $42.05 31 Dec 2025 fiscal year
Total assets $3.7B 31 Mar 2026 at period end
Total equity −$41.9M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

MTD earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $8.33 $947M
31 Dec 2025 FY 2025 $42.05 $4.03B
30 Sep 2025 Q3 2025 $10.57 $1.03B
30 Jun 2025 Q2 2024 $9.76 $983M

Reported figures & scheduled dates · SEC EDGAR filings

MTD institutional holders

SEC Form 13F

12 of the 45 institutional funds we track reported a MTD position for the quarter ended 31 Mar 2026 — a combined $1.1B; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Fundsmith Held (±25%) −2.1% shares 568,516 $717.0M
D. E. Shaw & Co. Added +3,239.0% shares 73,125 $92.2M
AQR Capital Management Added +44.9% shares 60,289 $76.0M
Citadel Advisors Trimmed −31.2% shares 58,054 $73.2M
Balyasny Asset Management Added +14,978.0% shares 47,948 $60.5M
Point72 Asset Management Trimmed −53.0% shares 28,762 $36.3M
Millennium Management Trimmed −39.0% shares 13,152 $16.6M
Renaissance Technologies New position 8,350 $10.5M
Man Group Trimmed −47.0% shares 7,143 $9.0M
Bridgewater Associates Added +974.9% shares 5,138 $6.5M

Source: SEC EDGAR 13F filings

MTD fails-to-deliver

SEC CNS data

On 30 Jun 2026, 480 shares of MTD failed to deliver (about $604K).

Settlement date Shares failed Notional % of shares out
30 Jun 2026 480 $604K 0.002%
15 Jun 2026 28 $32K <0.001%

Source: SEC fails-to-deliver (CNS) data